Patents by Inventor Naoya MIZUTANI

Naoya MIZUTANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid dosage form having excellent stability
    Patent number: 11925648
    Abstract: The present invention provides a solid dosage form having good stability, suspensibility in water and fluidity by preparing a solid dosage form containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a stabilizer, a sugar alcohol and/or a sugar, a water-soluble polymer and an inorganic substance.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: March 12, 2024
    Assignee: SHIONOGI & CO., LTD.
    Inventors: Naoya Mizutani, Masayuki Morimoto, Maki Okabe, Masaaki Ito, Go Kimura
  • SOLID DOSAGE FORM HAVING EXCELLENT STABILITY
    Publication number: 20210106589
    Abstract: The present invention provides a solid dosage form having good stability, suspensibility in water and fluidity by preparing a solid dosage form containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a stabilizer, a sugar alcohol and/or a sugar, a water-soluble polymer and an inorganic substance.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 15, 2021
    Applicant: Shionogi & Co., Ltd.
    Inventors: Naoya MIZUTANI, Masayuki MORIMOTO, Maki OKABE, Masaaki ITO, Go KIMURA
  • SUSTAINED RELEASE FORMULATION
    Publication number: 20160331688
    Abstract: The present invention is a sustained release formulation which is capable of controlling dissolution of a drug and of enduring peristaltic movement of the gastrointestinal tract. Specifically, the present invention is: a solid dosage form comprising a drug, croscarmellose sodium, an alkali metal salt or an alkoxide, and an alkali agent, wherein the alkali metal salt is a sodium salt or a potassium salt, and the alkali agent is a magnesium oxide; or a solid dosage form comprising a drug, croscarmellose sodium, an alkali metal salt or an alkoxide, and a water soluble polymer or a hydrophobic base, wherein the alkali metal salt is a sodium salt or a potassium salt.
    Type: Application
    Filed: January 30, 2015
    Publication date: November 17, 2016
    Inventors: Naoya MIZUTANI, Go KIMURA, Yukiko NISHINO, Satoshi SAKUMA